Life Science REIT has renegotiated its investment advisory deal with Ironstone and G10 Capital, slashing annual costs by £1m, which will add 0.3p in earnings per share.
From Q2 2025, the fee will move from being calculated
Life Science REIT has renegotiated its investment advisory deal with Ironstone and G10 Capital, slashing annual costs by £1m, which will add 0.3p in earnings per share.
From Q2 2025, the fee will move from being calculated
Our mission is to support you in finding and assessing investment and development opportunities faster.
Help us do just that by taking part in an exclusive product testing session.
Sign up nowKind regards,
The EG team